Sally Ann Forsyth is to join the Stevenage Bioscience Catalyst in March as chief executive to lead an expansion of the UK biomedical campus. Dr Forsyth, who is a chartered accountant and holds a PhD in molecular biology, comes from the Norwich Research Park where she has overseen the campus’ growth to include more than 80 companies.
Dr Forsyth began her career with Unilever where she worked in venture capital, technology transfer and alliance management.
Stevenage Bioscience Catalyst announced the appointment on 15 December 2017.
Copyright 2018 Evernow Publishing Ltd